InoCardia

We provide unique Work Loop models for the assessment of inotropy in human cardiac muscles and primary myocytes.

[InoCardia @InoCardia]

Snapshot from our presentation at @SafetyPharmSoc #SPSvirtual202 . Showcasing our exciting new pre chemistry In-Silico assay & post chemistry In-Vitro assay. @ProfH_Maddock @CovUni_SELS @innovateuk

[InoCardia @InoCardia]

Great to see our industrial PhD student Adam Linekar presenting data from his research at #SPSvirtual2021 @ProfH_Maddock @SafetyPharmSoc @CovUniResearch

[InoCardia @InoCardia]

The InoCardia team will be attending SPS2021! We have 5 posters (#17, 20, 21, 45, 46), 5 rapid fire presentations, booth 11, and a presentation Thursday 7th October at 12:30pm. Please come along and find out all the new exciting offerings we have. #SPSVirtual2021

[Prof Helen Maddock @ProfH_Maddock]

Looking forward to giving a talk today about Cancer Treatment-Related Cardiotoxicity & Approaches to Improve Anti-cancer Medication Development #saferdrugs @InoCardia @InnovateUK @CovUni_SELS

[Cresset @cressetgroup]

Robert Scoffin, CEO, reviews 2020 - from scientific developments, software and services solutions, to the important partnerships we have developed.

https://t.co/kPinQAXD6f

#ComputationalChemistry #DrugDiscovery @TrackingBoards @ChiroChem @InoCardia @openforcefield @3dneonet

[Prof Helen Maddock @ProfH_Maddock]

Well done team! Very proud!
@InoCardia @CovUni_SELS @BPS @innovateuk @SafetyPharmSoc @PaulN_CovUni @TheBHF https://t.co/3LHu9ySvbJ

[InoCardia @InoCardia]

First of 2 posters at @SafetyPharmSoc 2020. Development of a Predictive Inotropy In Silico Cardiac Safety Assay for Drug Candidate Screening. Large data set from our WorkLoop assay feeding into the In Silico model.
@ucb_news
@cressetgroup
@innovateuk

[InoCardia @InoCardia]

More news on our current #AI project. #DrugDiscovery #CardiacSafety #RandD #InSilicoPredictions

[UCB News @ucb_news]

#AI is changing medicines development for the better. Find out how UCB is partnering with others to use #machinelearning to develop safer medicines for patients.

[Coventry University Research and Innovation @CovUniResearch]

A @covcampus spin-out has been selected to test the safety of new drugs being developed to combat #COVID19. #InoCardia has been awarded £50,000 to ensure the new anti-virals will not cause damage to the heart. Read more: https://t.co/6cHTlRAwtk #CovResearch @CovUni_SELS

[InoCardia @InoCardia]

InoCardia are pleased to announce a collaboration with Cresset Discovery Services to develop improved computational methods for cardiac safety assessment. This collaboration also includes Coventry University, UCB and is supported by EIT Digital.
#CardiacSafety #DrugDevelopment

[Cresset @cressetgroup]

Cresset Discovery Services and InoCardia announce a one year collaboration to develop improved computational methods for cardiac safety assessment

https://t.co/uja5Zbi4Vm

#DrugDiscovery #CompChem #CardiacSafety #RandD #InSilicoPredictions